Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Nature Communications|January 17, 2020
Targeting the tumor vasculature with engineered cystine-knot miniproteinsBonny Gaby Lui, Nadja Salomon, Joycelyn Wüstehube-Lausch, et al.Science Immunology|September 20, 2022
Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5Alexander Muik, Bonny Gaby Lui, Maren Bacher, et al.Cell Reports|August 4, 2024
Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1Alexander Muik, Jasmin Quandt, Bonny Gaby Lui, et al.Open Forum Infectious Diseases|December 8, 2025
T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in ChildrenIsabel Vogler, Stephanie Renken, Rolf Hilker, et al.Computers in Biology and Medicine|February 12, 2023
Early computational detection of potential high-risk SARS-CoV-2 variantsKarim Beguir, Marcin J Skwark, Yunguan Fu, et al.Science Immunology|June 2, 2022
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopesJasmin Quandt, Alexander Muik, Nadine Salisch, et al.Science (New York, N.Y.)|January 18, 2022
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human seraAlexander Muik, Bonny Gaby Lui, Ann-Kathrin Wallisch, et al.Cell Reports|August 1, 2023
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunityAlexander Muik, Bonny Gaby Lui, Jasmin Quandt, et al.Science Immunology|November 15, 2022
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and miceAlexander Muik, Bonny Gaby Lui, Maren Bacher, et al.Pageof 1